EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study

A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis

(2013) Steven Georges et al.   EUROPEAN JOURNAL OF CANCER

Expression of CD147 is associated with prostate cancer progression

(2011) Wei-de Zhong et al.   INTERNATIONAL JOURNAL OF CANCER

ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth

(2011) Roopali Roy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer

(2011) Haining Zhu et al.   PROSTATE

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer

(2011) Jeffrey Tosoian et al.   TheScientificWorldJOURNAL

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2

(2009) F. Bougatef et al.   BLOOD

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer

(2009) Zhao-dong Han et al.   PATHOLOGY & ONCOLOGY RESEARCH

Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment

(2008) S. E. Pories et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Expression and Clinical Significance of CD147 in Genitourinary Carcinomas

(2008) Zhao-dong Han et al.   JOURNAL OF SURGICAL RESEARCH

CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer

(2008) Wei-de Zhong et al.   ONCOLOGY

The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functions

(2008) Karina Reiss et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY